Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 2529 entries
View as:

Safety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL Patients

Phase: N/A Priority: Normal
NCT ID: NCT02253277 Org: User:
Start: 02/18/15 End: 04/03/18 Due: 04/03/19

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Phase: N/A Priority: Normal
NCT ID: NCT03578367 Org: User:
Start: 11/22/18 End: 02/28/25 Due: 02/28/26

Study Conducted Among Patients With CML

Phase: N/A Priority: Normal
NCT ID: NCT05476562 Org: User:
Start: 03/08/21 End: 10/15/21 Due: 10/15/22

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

Phase: N/A Priority: Normal
NCT ID: NCT00891046 Org: User:
Start: 09/30/09 End: 12/31/14 Due: 12/31/15

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01103037 Org: User:
Start: 03/31/10 End: 09/30/10 Due: 09/30/11

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Phase: N/A Priority: Normal
NCT ID: NCT05666804 Org: User:
Start: 02/06/23 End: 10/31/25 Due: 10/31/26

Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04587622 Org: User:
Start: 10/30/20 End: 09/15/22 Due: 09/15/23

A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04828161 Org: User:
Start: 05/10/21 End: 01/27/22 Due: 01/27/23

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01558323 Org: User:
Start: 05/31/12 End: 03/31/13 Due: 03/31/14

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)

Phase: N/A Priority: Normal
NCT ID: NCT01585298 Org: User:
Start: 04/29/12 End: 12/12/16 Due: 12/12/17

Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec

Phase: N/A Priority: Normal
NCT ID: NCT00879242 Org: User:
Start: 02/28/09 End: - Due: -

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01870739 Org: User:
Start: 10/31/13 End: 06/30/15 Due: 06/30/16

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT01077544 Org: User:
Start: 04/14/11 End: 07/01/15 Due: 07/01/16

Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

Phase: N/A Priority: Normal
NCT ID: NCT00400400 Org: User:
Start: 10/31/06 End: - Due: -

Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00099892 Org: User:
Start: 05/31/04 End: 09/30/05 Due: 09/30/06

Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

Phase: N/A Priority: Normal
NCT ID: NCT01950819 Org: User:
Start: 12/03/13 End: 01/17/18 Due: 01/17/19

NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT07036718 Org: User:
Start: 07/31/25 End: 01/31/28 Due: 01/31/29

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00124280 Org: User:
Start: 07/31/05 End: - Due: -

Exploratory Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Phase: N/A Priority: Normal
NCT ID: NCT07039422 Org: User:
Start: 08/01/25 End: 08/30/30 Due: 08/30/31

A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT07039383 Org: User:
Start: 03/01/23 End: 06/18/24 Due: 06/18/25

The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT03300427 Org: User:
Start: 07/05/18 End: 03/23/22 Due: 03/23/23

ACZ885 for the Treatment of Abdominal Aortic Aneurysm

Phase: N/A Priority: Normal
NCT ID: NCT02007252 Org: User:
Start: 12/31/13 End: 10/31/15 Due: 10/31/16

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01576666 Org: User:
Start: 07/31/12 End: 04/30/15 Due: 04/30/16

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04362813 Org: User:
Start: 04/30/20 End: 12/22/20 Due: 12/22/21

Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg

Phase: N/A Priority: Normal
NCT ID: NCT01539213 Org: User:
Start: 02/29/12 End: 01/31/13 Due: 01/31/14